Pembrolizumab (anti-PD-1)

Pembrolizumab (anti-PD-1) is a potent, highly selective, fully humanized immunoglobulin (Ig) G4-kappa monoclonal antibody against PD-1 with potential immune checkpoint inhibitory and antineoplastic activities. MW : 146.286 KD.
Supplier Selleck Chemicals
Product # A2005
Sku # A2005-1mg*5
Pricing 1mg*5, $707.00
Feedback